Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial.

MLA

Rella Zoleko-Manego, et al. “Efficacy, Safety, and Tolerability of Albendazole and Ivermectin Based Regimens for the Treatment of Microfilaraemic Loiasis in Adult Patients in Gabon: A Randomized Controlled Assessor Blinded Clinical Trial.” PLoS Neglected Tropical Diseases, vol. 17, no. 8, Aug. 2023, p. e0011584. EBSCOhost, https://doi.org/10.1371/journal.pntd.0011584&type=printable.

APA

Rella Zoleko-Manego, Ruth Kreuzmair, Luzia Veletzky, Wilfrid Ndzebe-Ndoumba, Dorothea Ekoka Mbassi, Dearie G Okwu, Lia B Dimessa-Mbadinga-Weyat, Roselyne D Houtsa-Temgoua, Johannes Mischlinger, Matthew B B McCall, Peter G Kresmner, Selidji T Agnandji, Betrand Lell, Ayôla A Adegnika, Ghyslain Mombo-Ngoma, & Michael Ramharter. (2023). Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial. PLoS Neglected Tropical Diseases, 17(8), e0011584. https://doi.org/10.1371/journal.pntd.0011584&type=printable

Chicago

Rella Zoleko-Manego, Ruth Kreuzmair, Luzia Veletzky, Wilfrid Ndzebe-Ndoumba, Dorothea Ekoka Mbassi, Dearie G Okwu, Lia B Dimessa-Mbadinga-Weyat, et al. 2023. “Efficacy, Safety, and Tolerability of Albendazole and Ivermectin Based Regimens for the Treatment of Microfilaraemic Loiasis in Adult Patients in Gabon: A Randomized Controlled Assessor Blinded Clinical Trial.” PLoS Neglected Tropical Diseases 17 (8): e0011584. doi:10.1371/journal.pntd.0011584&type=printable.